Insiders who reported open-market trades in the last 12 months at the companies Christine Fox files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Richard D. Francis - $31.26M in TEVA purchases and sales in the last 12 months
Roberto Mignone - $22.82M in TEVA purchases and sales in the last 12 months
Eliyahu Sharon Kalif - $20.73M in TEVA purchases and sales in the last 12 months
Mark Sabag - $13.15M in TEVA purchases and sales in the last 12 months
Richard Daniell - $12.08M in TEVA purchases and sales in the last 12 months
Eric A. Hughes - $4.17M in TEVA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Christine Fox is a corporate insider, tracked as EVP, U.S. Commercial of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Christine Fox last file a Form 4?
The most recent primary Form 4 on record is dated 4 May 2026, one of 6 filings going back to 2024.
Has Christine Fox been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($3.08M) across all tracked filings.
Christine Fox is EVP, U.S. Commercial of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). 6 SEC Form 4 filings on record going back to 2024, most recently on 4 May 2026. Most recent open-market trade: sold $751K of TEVA on 4 May 2026. Lifetime open-market sales: $3.08M.
Recent transactions
10
The latest 10 SEC Form 4 transactions reported by Christine Fox.
InsiderAlpha's records for Christine Fox go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. 13 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
